|
1
|
Dambal S, Shah M, Mihelich B and Nonn L:
The microRNA-183 cluster: The family that plays together stays
together. Nucleic Acids Res. 43:7173–7188. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hannafon BN, Sebastiani P, de las Morenas
A, Lu J and Rosenberg CL: Expression of microRNA and their gene
targets are dysregulated in preinvasive breast cancer. Breast
Cancer Res. 13:R242011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirata H, Ueno K, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL, Hinoda Y and Dahiya R: MicroRNA-182-5p
promotes cell invasion and proliferation by down regulating FOXF2,
RECK and MTSS1 genes in human prostate cancer. PLoS One.
8:e555022013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu
C, Li J, Wang X and Song L: Unregulated miR-96 induces cell
proliferation in human breast cancer by downregulating
transcriptional factor FOXO3a. PLoS One. 5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lowery AJ, Miller N, Dwyer RM and Kerin
MJ: Dysregulated miR-183 inhibits migration in breast cancer cells.
BMC Cancer. 10:5022010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mihelich BL, Khramtsova EA, Arva N,
Vaishnav A, Johnson DN, Giangreco AA, Martens-Uzunova E, Bagasra O,
Kajdacsy-Balla A and Nonn L: miR-183-96-182 cluster is
overexpressed in prostate tissue and regulates zinc homeostasis in
prostate cells. J Biol Chem. 286:44503–44511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schaefer A, Jung M, Mollenkopf HJ, Wagner
I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G and Jung
K: Diagnostic and prognostic implications of microRNA profiling in
prostate carcinoma. Int J Cancer. 126:1166–1176. 2010.PubMed/NCBI
|
|
8
|
Ueno K, Hirata H, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL, Hinoda Y and Dahiya R: microRNA-183 is an
oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br J Cancer.
108:1659–1667. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Montecalvo A, Larregina AT, Shufesky WJ,
Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G,
Wang Z, et al: Mechanism of transfer of functional microRNAs
between mouse dendritic cells via exosomes. Blood. 119:756–766.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chevillet JR, Kang Q, Ruf IK, Briggs HA,
Vojtech LN, Hughes SM, Cheng HH, Arroyo JD, Meredith EK,
Gallichotte EN, et al: Quantitative and stoichiometric analysis of
the microRNA content of exosomes. Proc Natl Acad Sci USA.
111:14888–14893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Koga K, Matsumoto K, Akiyoshi T, Kubo M,
Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M
and Katano M: Purification, characterization and biological
significance of tumor-derived exosomes. Anticancer Res.
25:3703–3707. 2005.PubMed/NCBI
|
|
13
|
Dragovic RA, Gardiner C, Brooks AS,
Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL,
Dobson PJ, et al: Sizing and phenotyping of cellular vesicles using
nanoparticle tracking analysis. Nanomedicine. 7:780–788.
2011.PubMed/NCBI
|
|
14
|
Trams EG, Lauter CJ, Salem N Jr and Heine
U: Exfoliation of membrane ecto-enzymes in the form of
micro-vesicles. Biochim Biophys Acta. 645:63–70. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnstone RM, Adam M, Hammond JR, Orr L
and Turbide C: Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles
(exosomes). J Biol Chem. 262:9412–9420. 1987.PubMed/NCBI
|
|
16
|
Melo SA, Sugimoto H, O'Connell JT, Kato N,
Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et
al: Cancer exosomes perform cell-independent microRNA biogenesis
and promote tumorigenesis. Cancer Cell. 26:707–721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parolini I, Federici C, Raggi C, Lugini L,
Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A,
et al: Microenvironmental pH is a key factor for exosome traffic in
tumor cells. J Biol Chem. 284:34211–34222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Keller S, König AK, Marmé F, Runz S,
Wolterink S, Koensgen D, Mustea A, Sehouli J and Altevogt P:
Systemic presence and tumor-growth promoting effect of ovarian
carcinoma released exosomes. Cancer Lett. 278:73–81. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jang JY, Lee JK, Jeon YK and Kim CW:
Exosome derived from epigallocatechin gallate treated breast cancer
cells suppresses tumor growth by inhibiting tumor-associated
macrophage infiltration and M2 polarization. BMC Cancer.
13:4212013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Umezu T, Ohyashiki K, Kuroda M and
Ohyashiki JH: Leukemia cell to endothelial cell communication via
exosomal miRNAs. Oncogene. 32:2747–2755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gallo A, Tandon M, Alevizos I and Illei
GG: The majority of microRNAs detectable in serum and saliva is
concentrated in exosomes. PLoS One. 7:e306792012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng L, Sharples RA, Scicluna BJ and Hill
AF: Exosomes provide a protective and enriched source of miRNA for
biomarker profiling compared to intracellular and cell-free blood.
J Extracell Vesicles. 3:2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mihelich BL, Maranville JC, Nolley R,
Peehl DM and Nonn L: Elevated serum microRNA levels associate with
absence of high-grade prostate cancer in a retrospective cohort.
PLoS One. 10:e01242452015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang F, Zheng Z, Guo J and Ding X:
Correlation and quantitation of microRNA aberrant expression in
tissues and sera from patients with breast tumor. Gynecol Oncol.
119:586–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peehl DM: Are primary cultures realistic
models of prostate cancer? J Cell Biochem. 91:185–195. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peehl DM: Primary cell cultures as models
of prostate cancer development. Endocr Relat Cancer. 12:19–47.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Théry C, Amigorena S, Raposo G and Clayton
A: Isolation and characterization of exosomes from cell culture
supernatants and biological fluids. Curr Protoc Cell Biol Chapter.
3:Unit 3.22. 2006. View Article : Google Scholar
|
|
29
|
Luga V, Zhang L, Viloria-Petit AM,
Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and
Wrana JL: Exosomes mediate stromal mobilization of autocrine
Wnt-PCP signaling in breast cancer cell migration. Cell.
151:1542–1556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jansen FH, Krijgsveld J, van Rijswijk A,
van den Bemd GJ, van den Berg MS, van Weerden WM, Willemsen R,
Dekker LJ, Luider TM and Jenster G: Exosomal secretion of
cytoplasmic prostate cancer xenograft-derived proteins. Mol Cell
Proteomics. 8:1192–1205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak and Schmittgen: Analysis of relative
gene expression data using real-time quantitative PCR and the
2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Trajkovic K, Hsu C, Chiantia S, Rajendran
L, Wenzel D, Wieland F, Schwille P, Brügger B and Simons M:
Ceramide triggers budding of exosome vesicles into multivesicular
endosomes. Science. 319:1244–1247. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Llorente A, Skotland T, Sylvänne T,
Kauhanen D, Róg T, Orłowski A, Vattulainen I, Ekroos K and Sandvig
K: Molecular lipidomics of exosomes released by PC-3 prostate
cancer cells. Biochim Biophys Acta. 1831:1302–1309. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ohshima K, Inoue K, Fujiwara A, Hatakeyama
K, Kanto K, Watanabe Y, Muramatsu K, Fukuda Y, Ogura S, Yamaguchi K
and Mochizuki T: Let-7 microRNA family is selectively secreted into
the extracellular environment via exosomes in a metastatic gastric
cancer cell line. PLoS One. 5:e132472010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang
Q, Cheng P, Tang ZH and Huang F: Meta-analysis of microRNA-183
family expression in human cancer studies comparing cancer tissues
with noncancerous tissues. Gene. 527:26–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang PY, Gong HT, Li BF, Lv CL, Wang HT,
Zhou HH, Li XX, Xie SY and Jiang BF: Higher expression of
circulating miR-182 as a novel biomarker for breast cancer. Oncol
Lett. 6:1681–1686. 2013.PubMed/NCBI
|
